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Abstract
Introduction: AIRE is a transcriptional regulator playing a functional role in thymocyte education and negative
selection by controlling the expression of peripheral antigens in the thymus. Recently, the AIRE gene was identified
as a genetic risk factor for rheumatoid arthritis (RA) in genome wide association (GWA) studies performed in the
Japanese population. According to the available data this association is restricted to the Asian population.
However, different facts could influence the lack of association in Caucasian populations. The aim of this study was
to further investigate the possible role of the AIRE gene in susceptibility to RA in a Caucasian population.
Methods: A total of 472 Spanish Caucasian RA patients and 475 ethnically matched controls were included in the
study. Three single-nucleotide polymorphisms (SNPs) (rs2776377, rs878081 and rs1055311) with a minor allele
frequency >0.05 in the Caucasian population which were not included in the high-throughput platforms used in
the GWA studies performed in susceptibility to RA, and two SNPs (rs2075876 and rs1800520) associated with RA in
the Japanese population, were selected and genotyped using TaqMan assays.
Results: No significant differences in the distribution of the alleles of rs2776377, rs2075876, rs1055311 and
rs1800520 SNPs between RA patients and controls were observed. Nevertheless, the frequency of the C allele of
rs878081 was significantly higher among RA patients (80.5% vs. 74.6% in the control group, pc = 0.012, OR = 1.41,
95%CI 1.13-1.75). Regarding the distribution of the rs878081 genotypes, a higher frequency of CC homozygous
individuals was found in the RA patient group (65.56% vs. 56.47% in the control group, pc = 0.013, OR = 1.47, 95%
CI 1.12-1.93). The in silico analysis predicted lower affinity to the binding-site of a motif of the transcription NF-B
family and lower transcription levels of AIRE gene for the rs878081C risk variant
Conclusions: Our findings suggest that the AIRE gene is associated with susceptibility to RA in the Spanish
population. Probably, this association has not been detected in the European population in the GWA studies
because the earliest high-throughput platforms did not include SNP suitable markers (e.g. rs878081).
Introduction
Rheumatoid arthritis (RA) is a chronic systemic inflamma-
tory disease that often leads to disability from joint
damage and inflammation. Although RA is an uncommon
disease with a worldwide prevalence of approximately 1%,
this pathology has a large economic and societal cost in
terms of work-related disability [1]. Both environmental
and genetic factors are considered to be associated with
the onset and progression of this disease. Genome-wide
associations (GWA) studies have identified common
genetic variations associated with numerous complex dis-
eases [2]. Contrary to the candidate gene approach, in
which a limited number of genes chosen on the basis of
known or suspected biological considerations are tested,
the aim of GWA studies is to check association in the
whole genome without a priori hypotheses. Many gene
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loci have been identified as risk factors for RA in different
GWA studies in European and East Asian populations.
Some of these loci have been found to be restricted to a
particular ethnic group but others, such as, CCR6, STAT4
and TNFAIP3, have been described as associated with RA
in different populations [3]. Recently, the AIRE gene was
identified as a genetic risk factor for RA in a GWA study
performed in a Japanese population [4]. AIRE is a tran-
scriptional regulator primarily expressed in medullary thy-
mic epithelial cells, playing a functional role in thymocyte
education and negative selection by controlling the expres-
sion of peripheral antigens in the thymus [5]. Therefore,
AIRE is a good functional candidate in autoimmune
diseases regardless of the population. In fact, mutations in
this gene cause autoimmune polyendocrinopathy syn-
drome (APS1), which is one of the few known monogenic
autoimmune diseases. Nevertheless, AIRE has not been
identified as associated to RA in the European population,
either in a large-scale GWA study or in a meta-analysis of
GWA studies [6-10]. However, both of these studies had
strong detection power, and therefore, the association of
AIRE with RA, like that of PAD14, could be specific to
some populations, such as in the Japanese study [4]. How-
ever, this gene has different linkage disequilibrium (LD)
blocks in European and Asian populations (Figure 1), and
the earliest GWA high-throughput platforms do not
include any adequate tag single-nucleotide polymorphisms
(SNPs) for the European population. This fact could
influence the lack of association in Caucasian populations,
therefore, we decided to further investigate the possible




A total of 472 RA patients (351 women and 121 men) who
were unrelated were included in the study. All patients
meet the American College of Rheumatology (ACR)
revised RA criteria [11]. The mean (SD) age of onset was
49.23 (14.8) years. Information on rheumatoid factor,
anti-cyclic citrullinated peptide antibodies and Disease
Activity Score in 28 joints (DAS28) for RA activity was
obtained. Patients were rheumatoid factor-positive in
85.2% of the cases and anti-cyclic citrullinated peptide
antibodies were present in 82.2% of them. The control
population consisted of 475 ethnically matched healthy
bone marrow donors who were unrelated. All the subjects
were Spanish Caucasian, and they were recruited from
two Southern Spanish hospitals: Hospital Universitario
Virgen del Rocío (Sevilla) and Hospital Universitario
Virgen de las Nieves (Granada). No significant differences
in clinical features, ratio of rheumatoid factor and anti-
cyclic citrullinated peptide antibodies and DAS28 score
were observed between the two patient cohorts. The study
was approved by all local ethical committees of the corre-
sponding hospitals. Blood samples were obtained from
subjects after they provided written informed consent, and
were sent to Hospital Universitario Virgen del Rocio
where the genotyping study was performed. Genomic
DNA was extracted from blood leukocytes using QIAmp
DNA Mini Kit (Qiagen, Hilden, Germany) according to
the manufacturer’s recommendations and stored at -20ºC.
AIRE SNPs genotyping
An AIRE region (Chr21:44529072..44541978) [NCBI
Reference Sequence: NC_000021.7] LD plot was generated
from the Utah residents with Northern and Western Eur-
opean ancestry from the CEPH collection (CEU) with data
obtained from HapMap (Release 28, Phase II+III, NCBI
build 36 assembly, dbSNP b126). The LD solid spine
approach was used to define haplotype blocks in the CEU
population using the Haploview program (available at the
website [12]) (Figure 1). The rs2075876, which is asso-
ciated with RA in the Japanese population, was located in
the LD block Chr21:44529072...44534480 encompassing a
5.4 Kb region between 5’UTR and exon 6 in the CEU
population (Figure 1, CEU-block 1). A total of seven SNPs
were found in the HapMap project within this block, four
of them have a minor allele frequency (MAF) > 0.05
(rs2776377, rs878081, rs2075876 and rs1055311) and were
the ones selected for this study (Table 1). The SNP haplo-
types frequency estimation was performed using the
Haploview sotfware. Additionally, rs1800520, a non-
synonymous SNP (S278R), which is not included in
HapMap project, was also genotyped. Genotyping of con-
trols and RA patients was performed using TaqMan® SNP
Genotyping Assays (Applied Biosystems, Barcelona, Spain)
in a LightCycler 480 (Roche, Barcelona, Spain).
Bioinformatic analysis of AIRE expression
To check the effect of the variants in the AIRE gene
expression, two different approaches were used. First, the
effects of the variants on regulatory motifs were investi-
gated using the HaploReg database [13] and quantified
as: Predicted relative affinity = LOD(alt) - LOD(ref) [14],
where LOD is the logarithm of the odds, ref is the refer-
ence sequence, and alt is the alternative sequence. There-
fore, a negative result means that the predicted relative
affinity is higher for the reference sequence whereas a
positive result states that the predicted relative affinity is
higher for the alternative. Second, in order to analyze the
predicted expression levels, a gene-expression dataset of
lymphoblastoid cell lines derived from 210 unrelated
individuals from different populations of HapMap was
obtained from the Gene Expression Omnibus [GEO,
accession number GSE6536] database [15].
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Statistical analysis
Allele and haplotype frequency distributions were com-
pared using the chi square test, and a corrected P-value
(Pc) was calculated from 10,000 permutations (Haploview
program). Pc-values < 0.05 were considered statistically
significant. Odds ratios (ORs) and 95% CI were calculated
according to Wolf’s method using the Statcalc program
(Epi Info 2002; Centers for Disease Control and Preven-
tion, Atlanta, GA, USA). Statistical analysis of mRNA
AIRE expression was performed by the Joncheere-Terep-
stra method using the SPSS sotfware (version 18).
Results
Genotypes of rs2776377, rs878081, rs2075876, rs1055311
and rs1800520 were unequivocally assigned in 471 healthy
controls and 465 RA patients. The successful rate of
genotyping was > 98% for all the SNPs included, and the
study population was found to be in Hardy-Weinberg
Figure 1 Haplotype blocks described in the region Chr21:44529072..44541978 of the HapMap Project in the CEU and the JPT
populations. The linkage disequilibrium (LD) solid spine approach was used to define haplotype blocks. Standard color-coding was used for LD
plots: white (r2 = 0), shaded gray (0 <r2 < 1), black (r2 = 1). Squares without a number indicate D’ = 1. CEU, Utah residents with Northern and
Western European ancestry from the CEPH collection; JPT, Japanese in Tokyo, Japan.
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equilibrium for all the polymorphisms analyzed (P > 0.05).
Table 2 shows the frequencies of the four tag SNPs and
the rs1800520 in RA patients and healthy controls. No sig-
nificant differences in the distribution of the alleles of the
tag SNPs, rs2776377, rs2075876 and rs1055311 were
observed between RA patients and controls. Nevertheless,
the frequency of the C allele of the rs878081 SNP was sig-
nificantly higher among RA patients (80.5 vs. 74.6% in the
control group, Pc = 0.012, OR 1.41, 95% CI 1.13, 1.75) and
regarding the distribution of the rs878081 genotypes
(Table 3), a higher frequency of CC homozygous indivi-
duals was found in the RA patient group (65.56% vs.
56.47% in the control group, Pc = 0.013, OR 1.47, 95% CI
1.12, 1.93). Alleles of the non-synonymous rs1800520 had
the same frequency among patients and controls.
In the haplotype analysis, taking into account
rs2776377, rs878081, rs2075876 and rs1055311, six hap-
lotypes with frequencies > 0.05 were identified in our
population (Table 4). According to our results, the four
haplotypes bearing the rs878081C allele showed a higher
frequency in RA patients compared with controls,
although only one of them (GCGC) reached statistical
significance before permutation testing (P = 0.018, OR
1.38, 95% CI 1.05, 1.82). On the contrary, the two haplo-
types bearing the rs878081T alleles had a lower fre-
quency in the RA patients and one of them (GTGC)
remained statistically significant after permutation testing
(Pc = 0.014, OR 0.67, 95% CI 0.52, 0.87). All the major
haplotypes found in our population had the rs1800520C
allele except the haplotype GCAC, which was found with
both rs1800520 alleles (C 84% and G 16%).
Case-only phenotype analysis of RA patients revealed
no association between rs878081 alleles or haplotypes
and mean age at diagnosis, rheumatoid factor, anti-cyc-
lic citrullinated peptide antibodies or DAS28 score (data
not shown).
The in silico study using the HaploReg database [14], pre-
dicts a motif binding site that spans the rs878081 location
for transcription factors of the nuclear factor-kappa B (NF-
B family [16] The difference between the LOD score of
the T allele and the LOD score of the C allele was +2 (posi-
tive), therefore, this model predicts alterations of the affinity
to regulatory motifs, which is higher for the variant T than
for the C allele. Additionally, when the AIRE expression
levels were analyzed using the expression profiles from the
GEO database [15], a statistically significant difference in
the mean levels of expression of the rs878081 alleles was
found (P = 0.013). The transcription of AIRE was decreased
by the C allele compared with the T allele (Figure 2).
Table 1 MAF of the tag SNPs included in HapMap within
the Chr21:44529072
SNP Position MAF CEU MAF JPT
rs2776377 44529072 0.438 (G) 0.265 (A)
rs3761390 44529667 0.000 (G) 0.023 (G)
rs3746964 44530416 0.018 (C) 0.283 (C)
rs878081 44532705 0.336 (T) 0.173 (T)
rs2075876 44533581 0.123 (A) 0.347 (A)
rs1055311 44533996 0.261 (T) 0.009 (T)
rs2075877 44534480 0.019 (A) 0.320 (A)
rs1003854 44534535 0.345 (C) 0.292 (C)
rs941405 44534838 0.422 (G) 0.341 (C)
rs2073610 44534956 0.016 (C) 0.386 (C)
rs2073611 44535109 0.016 (A) 0.386 (A)
rs1078480 44535630 0.454 (G) 0.373 (A)
rs2741985 44536295 0.460 (C) 0.341 (T)
rs933150 44537016 0.381 (A) 0.270 (A)
rs2256817 44539814 0.413 (A) 0.337 (G)
rs760426 44540242 0.159 (G) 0.359 (G)
rs760427 44540419 0.156 (A) 0.443 (A)
rs1800522 44541978 0.433 (C) 0.367 (T)
MAF: minor allele frequency; SNP: single-nucleotide polymorphism. aRelease
28, Phase II+III, NCBI build 36 assembly, dbSNP b126. CEU, Utah residents with
Northern and Western European ancestry from the CEPH collection; JPT,
Japanese in Tokyo, Japan.







P-value Pc-valuea Odds ratio (95% CI) Japanese populationb
rs2776377
(5’UTR)
A 0.589 0.597 ns 0.265c
rs878081
(exon 5)
C 0.746 0.805 0.0022 0.0123 1.41 (1.13, 1.75) 0.827c
rs2075876
(intron 5)
A 0.114 0.116 ns 0.340d
rs1055311
(exon 6)
T 0.206 0.219 ns 0.012c
rs1800520
(exon 7)
G 0.017 0.019 ns 0.420d
RA, rheumatoid arthritis; SNP, single-nucleotide polymorphism, UTR: unstranlated region, ns: not significant at P > 0.05. aPc-value, 10,000-fold permutation testing;
bAllelic frequencies in the Japanese population; cHapMap Project, JPT (Japanese in Tokyo) population; dTerao et al. 2011 [4].
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Discussion
Replication studies in different populations have an
important role in the validation of common genetic var-
iation associated to complex diseases, strengthening the
confidence of initial association reports. In the present
work in a Spanish population we have replicated the
association between the AIRE gene and RA that was
recently identified in the Japanese population [4].
In the GWA study performed in the Japanese popula-
tion, two SNPs located in the AIRE gene region,
rs2075876 and rs760426, were described to be associated
with RA. Nevertheless, association with this gene had not
been found in European populations in previous GWA
studies [6-10]. Failure to identify the association in
European populations could be explained by several rea-
sons. Some of these reasons may be based on differences
between European and Asian populations in the poly-
morphism of this gene. According to HapMap data, the
region Chr21:44529072..44541978 included 18 tag SNPs,
of which 15 have an MAF > 0.20 in Japanese in Tokyo,
Japan (JPT) vs. 10 in CEU (Table 1). Additionally, four of
these tag SNPs with an MAF > 0.20 in JPT have an MAF
< 0.05 in CEU, whereas in contrast, MAF > 0.20 in CEU
and MAF < 0.05 is found only in one case. Specifically, the
SNPs identified as risk markers in the Japanese population,
have a much lower MAF in the Caucasian populations
included in the HapMap project (rs2075876A 0.123 in
CEU and 0.096 in Tuscan in Italy (TSI) and rs760426G in
0.159 CEU and 0.163 in TSI) than in the JPT (0.347 and
0.359, respectively) and other Asian populations (0.437
and 0.389 in Han Chinese in Beijing, China (CHB) and
0.417 and 0.413 in Chinese in Metropolitan Denver,
Colorado (CHD) respectively) included in this project.
Furthermore, the LD blocks in the AIRE region locus are
different in Caucasian and Asian populations (Figure 1).
The AIRE region is not included in GWA high-throughput
platforms of Affimetrix® used in several RA susceptibility
studies [6]. Additionally, the earliest GWA high-through-
put platforms of Illumina® used in RA susceptibility
studies do not include any tag SNPs with an MAF higher
than 0.2 for the European population within the LD block
where the rs2075876 is located (the LD block between
5’UTR and exon 6 of the AIRE region) [7,9]. For these
reasons, we focused our study on the LD block encom-
passing a 5.4 Kb around of 5’ AIRE region locus. The
rs878081 SNP was found to be associated to RA in our
population, even with a higher OR (1.41) than the repoted
in the Japanese population for the rs2075876 (OR = 1.18).
Therefore, according to our results, some genetic variants
with associations to disease that have been described to be
restricted to a specific ethnic group could lack this associa-
tion in other populations, because the tag SNPs of some
genome regions included in GWA platforms are more or
less suitable according to the population. This fact could
also explain why some associations found in candidate
gene studies may not be replicated in GWA studies, due
to suboptimal representation and coverage of the risk var-
iants with the tag SNPs used in the high-throughput
platforms [17,18].
The association study performed with haplotypes
showed that the susceptibility is strongly influenced by
the rs878081 SNP, because all those haplotypes bearing
the rs878081C allele showed a higher frequency in RA
patients compared with controls. Despite the different
distribution of haplotypes among European and Asian
populations, the risk allele rs2075876A in the Japanese
population is in LD with the risk allele rs878081C in the
Spanish population. The rs878081 is located in exon 5






a Odds ratio (95% CI)
CC 0.564 0.656 0.005 0.0136 1.47 (1.12, 1.93)
CT + TT 0.436 0.344
RA, rheumatoid arthritis; SNP, single-nucleotide polymorphism. aPc-value, 10,000-fold permutation testing.





P-value Pc-value* Odds ratio (95% CI)
rs2776377 rs878081 rs2075876 rs1055311
A C G C 0.324 0.331 ns 1.03 (0.85, 1.24)
A C G T 0.182 0.193 ns 1.09 (0.86, 1.38)
G T G C 0.174 0.124 0.0025 0.0141 0.67 (0.52, 0.87)
G C G C 0.110 0.146 0.0182 ns 1.38 (1.05, 1.82)
G C A C 0.106 0.111 ns 1.05 (0.78, 1.40)
A T G C 0.076 0.065 ns 0.84 (0.59, 1.20)
RA, rheumatoid arthritis; ns, not significant at P > 0.05. *Pc-value, 10,000-fold permutation testing.
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but it is a synonymous polymorphism, and therefore, it
does not introduce functional alterations in the AIRE
protein; hence, other non-synonymous SNPs could con-
tribute to the disease. The HaploReg database predicts a
lower affinity of the factor-binding site to the motif of
transcription of the NF-B family for the rs878081C
risk allele [14,16]. Additionally, results of the in silico
analysis of the dataset of lymphoblastoid cell lines of
GEO showed that similarl to the rs2075876A risk allele
[4], transcription levels of AIRE are lower for the
rs878081C risk allele [15]. It has been demonstrated
that NF-B2 is required for the transcriptional regula-
tion of the AIRE gene in the thymus, contributing to the
maintenance of central tolerance in an AIRE-dependent
manner [19]. According to our results, the lower affinity
to the C allele for the transcription factor motif could
be the cause of the lower transcription levels found in
the in silico analysis. These lower levels of transcription
of the gene could promote failure of negative selection
in the thymus, and as a consequence, increase the survi-
val of autoreactive T cell clones.
We also checked the association of the non-synon-
ymous SNP, rs1800520 (S278R) located in the exon 7,
which was found to be associated to RA in the Japanese
population. Nevertheless, no differences in allele frequen-
cies of this SNP were found when comparing patients
and controls in our population. The MAF of the
rs1800520 in the Spanish population was 0.017 vs. 0.420
in the Japanese population [4]. This is probably the cause
of the discrepancies observed in the association with
rs1800520 in both populations. Finally, in our study we
did not include the rs760426, which was also found to be
associated with RA in the Japanese population, because
the MAF of this SNP in the CEU population is < 0.2 and
it is located in another LD block.
Conclusions
In summary, this is the first study establishing a relation-
ship between the AIRE gene and the susceptibility to RA
in a European population. This relationship could not
have been detected in the GWA studies because of the
differences in both the frequency of SNPs and in the struc-
ture of the linkage blocks between the different ethnic
groups that would determine better or worse adequacy of
the SNP markers included in the platforms.
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